Microfluidics Market to Witness a Healthy Growth by 2030

According to Precedence Research, during the forecast period of 2022 to 2030, the global microfluidics market is estimated to develop at a compound annual growth rate (CAGR) of 16.5%. The global microfluidics market was valued at USD 18 billion in 2021, and it is predicted to exceed USD 62 billion by 2030. The study investigates several elements and their consequences on the growth of the microfluidics market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1116

Growth Factor

Rising demand for Point of Care (POC) testing in a wide range of applications because of the benefits associated with the incorporation of microfluidics along with high return on investments anticipated to propel the market growth of microfluidics during the analysis period. In addition, high-throughput screening methodologies, low-volume sample analysis, and increased demand for in vitro diagnostics (IVD) expected to offer numerous growth opportunities for the players operating in the microfluidics market during the forthcoming years. On the contrary, lack of market visibility for the microfluidics products coupled with high prices of the microfluidics sensors and integrated systems is the key factor that restrict the market growth.

Microfluidics has been successfully applied for the manufacturing of a diverse range of commercial products. For example, integrated fluidic circuits designed by the Fluidigm Corporation offers sample throughput that is comparatively high and provides cost-effective solutions for multiplex single-nucleotide polymorphism genotyping. Likewise, another manufacturer named Quanta Life that provides droplet-based microfluidic solutions for carrying out digital PCR for quantification of nucleic acids.

Caliper Life Sciences offers LabChip systems that use a glass microfluidic chip to receive a high-throughput fluorescent and electrophoretic analysis of protein fragments and nucleic acid. Further, technological advancement is the key factor that drives the market growth. For instance, organ-on-chips are the microfluidic devices that are used for culturing living cells in constantly perfused and micrometer-sized chambers to model physiological functions of tissues and organs.

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1116

This report focuses on microfluidics market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall microfluidics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Report Highlights

• North America emerged as the largest share holder in the global microfluidics market owing to the presence of well-established market players in the region
• The Asia Pacific encountered to be the fastest growing market because of affordable labor, sophisticated research infrastructure, and adoption of microfluidic platforms
• The PDMS-based microfluidic chips segment led the global microfluidics market in terms of revenue in 2019 and expected to register the fastest growth rate over the analysis period
• Polymer-based microfluidic devices proved as a better alternative to the glass and silicon-based microfluidic devices
• Based on technology, the medical technology segment dominated the global market in 2019 owing to the major benefits offered by the microfluidics for the POC diagnostics
• The lab-on-a-chip application accounted for the largest value share in the global market and estimated to continue its dominance throughout the analysis period

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of microfluidics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of microfluidics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the microfluidics market.

Some of the prominent players in the microfluidics market include:

• Agilent Technologies, Inc.
• Illumina, Inc.
• Perkinelmer, Inc.
• Life Technologies Corporation
• Danaher
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd
• Abbott Laboratories
• Fluidigm Corporation
• Qiagen N.V.
• Thermo Fischer Scientific
• Biomérieux
• Cellix Ltd.
• Elveflow
• Micronit Micro Technologies B.V.

Segments Covered in the Report

By Material

• Glass
• Silicon
• PDMS
• Polymers
• Others

By Technology

• Non-Medical
• Medical
  • Gel Electrophoresis
  • PCR & RT-PCR
  • ELISA
  • Microarrays
  • Others

By Application

• Organs-on-chips
• Lab-on-a-chip
• Continuous Flow Microfluidics
• Acoustofluidics and Microfluidics
• Optofluidics and Microfluidics
• Electrophoresis and Microfluidics

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Microfluidics Market, By Material

7.1. Microfluidics Market, by Material Type, 2021-2030
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Microfluidics Market, By Application

8.1. Microfluidics Market, by Application, 2021-2030
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Microfluidics Market, By Technology

9.1. Microfluidics Market, by Technology, 2021-2030
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Microfluidics Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. Market Revenue and Forecast, by Technology (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Technology (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Technology (2017-2030)

Chapter 11. Company Profiles

11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1116

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com